Clinical studies on the management of periodontal diseases utilizing subantimicrobial dose doxycycline (SDD)

Pharmacological Research

Volumn 63, Issue 2, 2011, Pages 114-120

  Caton, Jack ^a   Ryan, Maria Emanuel ^b  

^a UNIVERSITY OF ROCHESTER   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Host modulatory therapy (HMT); Intensive periodontal therapy (IPT); Matrix metalloproteinases (MMPs); Periodontitis; Sub antimicrobial dose doxycycline (SDD)

Indexed keywords

C REACTIVE PROTEIN; COLLAGENASE; DOXYCYCLINE; HEMOGLOBIN A1C; INTERLEUKIN 1; MINOCYCLINE; NEUTROPHIL COLLAGENASE; PLACEBO; TETRACYCLINE;

ARTICLE; DISEASE ACTIVITY; DOSE RESPONSE; DRUG APPROVAL; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; ENZYME INHIBITION; HOST PARASITE INTERACTION; HUMAN; NONHUMAN; OSTEOPOROSIS; PERIODONTITIS; PRIORITY JOURNAL; TREATMENT PLANNING;

ANTI-BACTERIAL AGENTS; BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; DOXYCYCLINE; HOST-PARASITE INTERACTIONS; HUMANS; MATRIX METALLOPROTEINASES; PERIODONTAL DISEASES; PERIODONTITIS;

EID: 79251608050     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2010.12.003     Document Type: Article

References (35)

1. J.E. Maynard Periodontics Periodontal disease management: a conference for the dental team 1993 American Academy of Periodontology Boston
2. S. Offenbacher Periodontal diseases: pathogenesis Ann Periodontol 1 1996 821 878
3. K.S. Kornman Host modulation as a therapeutic strategy in the treatment of periodontal disease Clin Infect Dis 28 1999 520 526
4. R.C. Page Milestones in periodontal research and the remaining critical issues J Periodontol Res 34 1999 331 339
5. R.C.K.K. Page The pathogenesis of human periodontitis: an introduction Periodontol 2000 14 1997 9 11
6. P.M. Preshaw, M.E. Ryan, and W.V. Giannobile Host modulation agents M.G. Newman, H.H. Takei, P.R. Klokkevold, Carranza FA" Carranza's clinical periodontology 10th ed. 2006 Elsevier Publishers St. Louis: Saunders 813 827
7. L.M. Golub, S. Ciancio, and N.S. Ramamurthy Low dose doxycycline therapy: effect on gingival and crevicular fluid collagenase activity in humans J Periodontol Res 25 1990 321 330
8. L.M. Golub, M. Wolff, and H.M. Lee Further evidence that tetracyclines inhibit collagenase activity in human crevicular fluid and from other mammalian sources J Periodontol Res 20 1985 12 23
9. L.M. Golub, T. Sorsa, and H.M. Lee Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva J Clin Periodontol 22 1995 100 109
10. L.M. Golub, T.F. McNamara, and M.E. Ryan Adjunctive treatment with subantimicrobial doses of doxycycline effects on gingival fluid collagenase activity and attachment loss in adult periodontitis J Clin Periodontol 28 2001 146 156
11. C. Walker, J. Thomas, and S. Nango Long-term treatment with subantimicrobial dose doxycycline exerts no antimicrobial effect on the subgingival microflora associated with adult periodontitis J Periodontol 71 2000 1465 1471
12. J. Thomas, C. Walker, and M. Bradshaw Long-term use of subantimicrobial dose doxycycline does not lead to changes in antimicrobial susceptibility J Periodontol 1 2000 1472 1483
13. J.Y. Lee, Y.M. Lee, and S.Y. Shin Effect of subantimicrobial dose doxycycline as an effective adjunct to scaling and root planing J Periodontol 75 2004 1500 1508
14. R.A. Ashley Clinical trials of a matrix metalloproteinase inhibitor in human periodontal disease, SDD Clinical Research Team Ann N Y Acad Sci 878 1999 335 346
15. P.M. Preshaw Host response modulation in periodontitis Periodontol 2000 48 2008 92 110
16. J.G. Caton, S.G. Ciancio, and T.M. Blieden Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitis J Periodontol 71 2000 521 532
17. M.J. Novak, L.P. Johns, and R.C. Miller Adjunctive benefits of subantimicrobial dose doxycycline in the management of severe, generalized, chronic periodontitis J Periodontol 73 2002 762 769
18. P.M. Preshaw, A.F. Hefti, and M.J. Novak Subantimicrobial dose doxycycline enhances the efficacy of scaling and root planing in chronic periodontitis: a multicenter trial J Periodontol 75 2004 1068 1076
19. G. Emingil, G. Atilla, and T. Sorsa The effect of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis J Periodontol 75 2004 106 115 (Pubitemid 38312775)
20. D.H. Choi, I.S. Moon, and B.K. Choi Effects of sub-antimicrobial dose doxycycline therapy on crevicular fluid MMP-8, and gingival tissue MMP-9, TIMP-1 and IL-6 levels in chronic periodontitis J Periodontol Res 39 2004 20 26
21. A. Gurkan, S. Cinarcik, and A. Huseyinov Adjunctive subantimicrobial dose doxycycline: effect on clinical parameters and gingival crevicular fluid transforming growth factor-beta levels in severe, generalized chronic periodontitis J Clin Periodontol 32 2005 244 253
22. P.M. Preshaw, A.F. Hefti, and M.H. Bradshaw Adjunctive subantimicrobial dose doxycycline in smokers and non-smokers with chronic periodontitis J Clin Periodontol 32 2005 610 616
23. A.R. Mohammad, P.M. Preshaw, and M.H. Bradshaw Adjunctive subantimicrobial dose doxycycline in the management of institutionalised geriatric patients with chronic periodontitis Gerodontology 22 2005 37 43
24. R.N.M. Gorska The effects of the initial treatment phase and of adjunctive low-dose doxycycline therapy on clinical parameters and MMP-8, MMP-9, and TIMP-1 levels in the saliva and peripheral blood of patients with chronic periodontitis Arch Immunol Ther Exp 54 2006 419 426
25. I. Needleman, J. Suvan, and M.S. Gilthorpe A randomized-controlled trial of low-dose doxycycline for periodontitis in smokers J Clin Periodontol 34 2007 325 333
26. L.M. Golub, H.M. Lee, and R.A. Greenwald A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis Inflamm Res 46 1997 310 319
27. J.G. Caton, S.G. Ciancio, and T.M. Blieden Subantimicrobial dose doxycycline as an adjunct to scaling and root planing: post-treatment effects J Clin Periodontol 28 2001 782 789
28. M.E. Ryan, H.M. Lee, and M.K. Bookbinder Treatment of genetically susceptible patients with a subantimicrobial dose of doxycycline J Dent Res 79 2000 608 [Abstract #3719]
29. K.F. Al-Shammari, W.V. Giannobile, and W.A. Aldredge Effect of non-surgical periodontal therapy on C-telopeptide pyridinoline cross-links (ICTP) and interleukin-1 levels J Periodontol 72 2001 1045 1051
30. J.B. Payne, J.A. Stoner, and P.V. Nummikoski Subantimicrobial dose doxycycline effects on alveolar bone loss in post-menopausal women J Clin Periodontol 34 2007 776 787
31. L.M. Golub, H.M. Lee, and J.A. Stoner Subantimicrobial-dose doxycycline modulates gingival crevicular fluid biomarkers of periodontitis in postmenopausal osteopenic women J Periodontol 79 2008 1409 1418
32. R.A. Reinhardt, J.A. Stoner, and L.M. Golub Efficacy of sub-antimicrobial dose doxycycline in post-menopausal women: clinical outcomes J Clin Periodontol 34 2007 768 775
33. C. Walker, S. Puumala, and L.M. Golub Subantimicrobial dose doxycycline effects on osteopenic bone loss: microbiologic results J Periodontol 78 2007 1590 1601
34. D.L. Brown, K.K. Desai, and B.A. Vakili Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial Arterioscler Thromb Vasc Biol 24 2004 733 738
35. S.P. Engebretson, J. Hey-Hadavi, and R. Celenti Low dose doxycycline treatment reduces glycosylated hemoglobin in patients with type 2 diabetes: a randomized controlled trial J Dent Res 82 Special Issue 2003 23 25 [Abstract #1445]